Tickers

1. Composite Trajectory Verdict

Given AOS's business model as a manufacturer with significant shareholder returns via dividends and buybacks, all three statements carry roughly equal weight.

Composite Trajectory: Mixed

The annual income statement (2023‑2025) shows essentially flat net earnings and rising EPS due to share count reduction, but the first half of 2026 reveals a 15.9% year‑over‑year decline in net earnings and a 13% drop in diluted EPS. Cash flow from operations recovered in 2025 and surged 42% in H1 2026, yet investing cash flow swung deeply negative due to the $470 million Leonard Valve acquisition. The balance sheet deleveraged through 2025 (debt‑to‑capitalization fell to 7.7%), but the acquisition drove leverage to 25.7% by June 2026. North America segment sales and earnings grew in H1 2026, while Rest of World sales and earnings contracted sharply, resulting in a mixed overall picture.

2. Red Flags

• Leverage spike: Debt‑to‑capitalization jumped from 7.7% at Dec 31 2025 to 25.7% at June 30 2026 after the $470 million term loan for Leonard Valve (10-Q 2026-06-30, Liquidity & Capital Resources).
• Restructuring recurrence: A $22.6 million restructuring charge hit Q2 2026 (North America water treatment) after zero restructuring expense in all of 2025 (10-Q 2026-06-30, Condensed Statements of Operations; 10-K 2025-12-31, Consolidated Statements of Earnings).
• Rest of World deterioration: China third‑party sales fell 28% in local currency in Q2 2026; Rest of World segment earnings dropped 59.7% in Q2 and 49.8% in H1 2026 (10-Q 2026-06-30, MD&A).
• Gross margin compression: Consolidated gross margin fell to 38.6% in H1 2026 from 39.1% in H1 2025 (10-Q 2026-06-30, Condensed Statements of Operations).
• Interest expense doubling: H1 2026 interest expense rose to $15.2 million from $7.5 million in H1 2025 (10-Q 2026-06-30, Condensed Statements of Operations).
• Guidance reduction: Full‑year 2026 diluted EPS guidance narrowed to $3.60‑3.75 from prior $3.60‑3.90, below 2025’s $3.85 (10-Q 2026-06-30, Outlook).
• Goodwill concentration: Goodwill increased to $915.2 million at June 30 2026 (including $210.1 million from Leonard Valve) while Rest of World goodwill fell to $119.1 million at Dec 2025, raising impairment risk if China weakness persists (10-Q 2026-06-30, Consolidated Balance Sheets; 10-K 2025-12-31, Note 9).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP net earnings were $556.6 million (2023), $533.6 million (2024), and $546.2 million (2025), essentially flat with a dip in 2024 (10-K 2025-12-31, Consolidated Statements of Earnings). Diluted EPS rose from $3.69 to $3.63 to $3.85 over the same period, aided by share repurchases (10-K 2025-12-31, Consolidated Statements of Earnings). In contrast, H1 2026 net earnings fell 15.9% year‑over‑year to $242.9 million, and diluted EPS declined 13% to $1.75 (10-Q 2026-06-30, Condensed Statements of Operations). North America segment earnings decreased 8.0% in H1 2026, while Rest of World segment earnings plunged 49.8% (10-Q 2026-06-30, MD&A). Gross margin contracted to 38.6% in H1 2026 from 39.1% in H1 2025 (10-Q 2026-06-30, Condensed Statements of Operations). The company’s 2026 guidance implies diluted EPS of $3.60‑3.75, below the 2025 level of $3.85 (10-Q 2026-06-30, Outlook).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow dipped to $581.8 million in 2024 then recovered to $616.8 million in 2025 (10-K 2025-12-31, Consolidated Statements of Cash Flows). Free cash flow (operating cash flow less capex) followed a similar pattern: $473.8 million in 2024 and $546.0 million in 2025 (10-K 2025-12-31, Non‑GAAP Measures). H1 2026 operating cash flow jumped 42% to $253.8 million and free cash flow rose 67% to $233.3 million, driven by working capital management (10-Q 2026-06-30, Non‑GAAP Measures). However, investing cash flow swung to -$471.8 million in H1 2026 due to the $470 million Leonard Valve acquisition (10-Q 2026-06-30, Condensed Statements of Cash Flows). Cash and equivalents ended June 2026 at $181.3 million versus $174.5 million at Dec 2025 (10-Q 2026-06-30, Consolidated Balance Sheets).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Through 2025 the balance sheet strengthened: total debt fell from $193.2 million at Dec 2024 to $155.0 million at Dec 2025, and leverage (debt‑to‑capitalization) declined from 9.3% to 7.7% (10-K 2025-12-31, Liquidity and Capital Resources). The Leonard Valve acquisition reversed this trend: total debt reached $637.5 million at June 30 2026 (current portion $39.5 million + long‑term $598 million), pushing leverage to 25.7% (10-Q 2026-06-30, Liquidity & Capital Resources; Consolidated Balance Sheets). Goodwill rose to $915.2 million from $710.6 million and other intangibles to $589 million from $362.3 million (10-Q 2026-06-30, Consolidated Balance Sheets). Stockholders’ equity edged down to $1,841.9 million from $1,858.0 million despite H1 2026 net earnings of $242.9 million, as share repurchases of $162.4 million continued (10-Q 2026-06-30, Condensed Statements of Cash Flows; Consolidated Balance Sheets).

6. Data Gaps

• Quarterly income statement and cash flow data for Q1 2026, Q3 2025, and Q4 2025 (the 10‑Q filings for 2026‑03‑31, 2025‑09‑30, and 2025‑06‑30 were truncated in the provided documents).
• Segment‑level operating cash flows (not disclosed in the filings).
• Disaggregated Rest of World sales by country (India, Europe) beyond China.
• Quantified impact of potential tariff changes on 2026 results.
• Outcome and timing of the strategic assessment of the China business.
• Detailed purchase price allocation for Leonard Valve (preliminary allocation expected by end of Q2 2026).
• Projected annual amortization expense for newly acquired Leonard Valve intangibles.